Back
Cartesian Therapeutics Stock Price Chart
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
34
RNAC
Cartesian Therapeutics
Last Price:
18.29
Seasonality Move:
13.13%
7 Day Trial
ALL ACCESS PASS
$
7
Trade on Tuesday. Profit on Friday. Rinse & Repeat
Get the full details now.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RNAC is experiencing selling pressure, which indicates risk of future bearish movement.
Cartesian Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 17.6 | Buy |
| 20-day SMA: | 18.93 | Sell |
| 50-day SMA: | 19.41 | Sell |
| 200-day SMA: | 19.97 | Sell |
| 8-day EMA: | 17.91 | Buy |
| 20-day EMA: | 18.67 | Sell |
| 50-day EMA: | 18.89 | Sell |
| 200-day EMA: | 20.92 | Sell |
Cartesian Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.68 | Sell |
| Relative Strength Index (14 RSI): | 45.67 | Sell |
| Chaikin Money Flow: | -71548 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (17.61 - 21.41) | Sell |
| Bollinger Bands (100): | (14.35 - 20.33) | Buy |
Cartesian Therapeutics Technical Analysis
| Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Cartesian Therapeutics Stock
Is Cartesian Therapeutics Stock a Buy?
- Cartesian Therapeutics share price is 17.91 while RNAC 8-day simple moving average is 17.60, which is a Buy signal.
- The stock price of RNAC is 17.91 while Cartesian Therapeutics 20-day SMA is 18.93, which makes it a Sell.
- Cartesian Therapeutics 50-day simple moving average is 19.41 while RNAC share price is 17.91, making it a Sell technically.
- RNAC stock price is 17.91 and Cartesian Therapeutics 200-day simple moving average is 19.97, creating a Sell signal.
RNAC Technical Analysis vs Fundamental Analysis
Sell
34
Cartesian Therapeutics (RNAC)
is a Sell
Is Cartesian Therapeutics a Buy or a Sell?
-
Cartesian Therapeutics stock is rated a Sell
The current Cartesian Therapeutics [RNAC] share price is $17.91. The Score for RNAC is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
Cartesian Therapeutics Stock Info
Market Cap:
455.18M
Price in USD:
17.91
Share Volume:
106.38K
Cartesian Therapeutics 52-Week Range
52-Week High:
42.60
52-Week Low:
11.67
Sell
34
Cartesian Therapeutics (RNAC)
is a Sell
Cartesian Therapeutics Share Price Forecast
-
What is the Cartesian Therapeutics stock price today?
The Cartesian Therapeutics stock price is 17.91 USD today. -
Will RNAC stock go up or go down?
Cartesian Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Cartesian Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cartesian Therapeutics is overvalued.
Is Cartesian Therapeutics Stock a Buy?
- Cartesian Therapeutics share price is 17.91 while RNAC 8-day exponential moving average is 17.91, which is a Buy signal.
- The stock price of RNAC is 17.91 while Cartesian Therapeutics 20-day EMA is 18.67, which makes it a Sell.
- Cartesian Therapeutics 50-day exponential moving average is 18.89 while RNAC share price is 17.91, making it a Sell technically.
- RNAC stock price is 17.91 and Cartesian Therapeutics 200-day simple moving average is 20.92, creating a Sell signal.
Fundamental Analysis of Cartesian Therapeutics
Is Cartesian Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.90 per share, and an increase next year of $1.70 per share.
Technical Analysis of Cartesian Therapeutics
Should I short Cartesian Therapeutics stock?
- RNAC Moving Average Covergence Divergence (MACD) indicator is -0.68, suggesting Cartesian Therapeutics is a Sell
- Cartesian Therapeutics Relative Strength Index (RSI) is 45.67, which suggest Cartesian Therapeutics is oversold
- The Bollinger Bands (25) for Cartesian Therapeutics is (17.61 - 21.41), which suggest Cartesian Therapeutics is a Buy
- The Bollinger Bands (100) for Cartesian Therapeutics is (14.35 - 20.33), which suggest Cartesian Therapeutics is a Buy
* Cartesian Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.